Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses
- DOI
- 10.1093/ecco-jcc/jjag133
- Published
- 2026-09
- Container
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjag133,
title = {Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses},
author = {Lorenzo Giorio and Steve De Vos and Maikel Luis Colli and Didier Merciris and Eva Vissers and Tommaso Innocenti and Fabrice Kolb and Marc Ferrante and João Guedelha Sabino and Séverine Vermeire and Kaline Arnauts and Bram Verstockt},
year = {2026},
journal = {Journal of Crohn's and Colitis},
doi = {10.1093/ecco-jcc/jjag133},
url = {https://doi.org/10.1093/ecco-jcc/jjag133}
}RIS
TY - JOUR TI - Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses AU - Lorenzo Giorio AU - Steve De Vos AU - Maikel Luis Colli AU - Didier Merciris AU - Eva Vissers AU - Tommaso Innocenti AU - Fabrice Kolb AU - Marc Ferrante AU - João Guedelha Sabino AU - Séverine Vermeire AU - Kaline Arnauts AU - Bram Verstockt PY - 2026 JO - Journal of Crohn's and Colitis DO - 10.1093/ecco-jcc/jjag133 UR - https://doi.org/10.1093/ecco-jcc/jjag133 ER -
APA
Giorio, L., Vos, S. D., Colli, M. L., Merciris, D., Vissers, E., Innocenti, T., Kolb, F., Ferrante, M., Sabino, J. G., Vermeire, S., Arnauts, K., & Verstockt, B. (2026). Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjag133
Source records
- crossref · retrieved 2026-09-25T11:36:47.635Z